You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 29 No. 2, August 1973 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Various Enzymes Involved With Putative Neurotransmitters

Regional Distribution in the Brain of Deceased Mentally Normal, Chronic Schizophrenics or Organic Brain Syndrome Patients

Edward F. Domino, MD; Rache R. Krause; Joanne Bowers

Arch Gen Psychiatry. 1973;29(2):195-201.


Abstract

Levels of protein and several enzymes involved with neurotransmitters Were determined in 15 brain areas of subjects diagnosed as chronic schizophrenics (CS), organic brain syndrome (OBS, an older age group), or mentally normal (N) prior to death.

Enzymes studied were total cholinesterase (TChE), acetylcholinesterase (AChE), pseudocholinesterase (ChE), choline acetyltransferase (ChAc), monoamine oxidase (MAO), and N-methyltransferase (NMT). The only significant decrease in protein was in the temporal cortex of the OBS group. The septal area of CS patients ( [ill] <.05) and the cingulate gyrus of the OBS group ( [ill] <.01) showed significantly less TChE activity than the mentally normal group. The septal area of the CS also had less AChE activity ( [ill] <.05). ChE activity was greater than normal in the CS patients previously on neuroleptic drugs. ChAc activity was significantly increased ( [ill] <.05) in the medial amygdala of CS patients. MAO activity did not differ significantly between groups. NMT activity was extremely low throughout and showed no statistically significant differences among the diagnostic catagories.

The majority of brain areas sampled showed no significant differences in enzyme activity among the three groups. The differences that were observed must be considered preliminary and subject to further validation under better controlled conditions.



Author Affiliations

Detroit

From the Michigan Neuropsychopharmacology Research Program, the Department of Pharmacology, Lafayette Clinic, Detroit, and the University of Michigan, Ann Arbor.


Footnotes

Accepted for publication Feb 5, 1973.

Reprint requests to Lafayette Clinic, 951 Lafayette, Detroit, MI 48207 (Dr. Domino).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Activities of Types A and B MAO and Catechol-O-methyltransferase in Blood Cells and Skin Fibroblasts of Normal and Chronic Schizophrenic Subjects
Groshong et al.
Arch Gen Psychiatry 1978;35:1198-1205.
ABSTRACT  

Possible Changes in Striatal and Limbic Cholinergic Systems in Schizophrenia
McGeer and McGeer
Arch Gen Psychiatry 1977;34:1319-1323.
ABSTRACT  

Monoamine Metabolism in Human Brain
Robinson et al.
Arch Gen Psychiatry 1977;34:89-92.
ABSTRACT  

Platelet Monamine Oxidase in Schizophrenia: An Investigation in Drug-Free Chronic Hospitalized Patients
Owen et al.
Arch Gen Psychiatry 1976;33:1370-1373.
ABSTRACT  

Multiple Forms of Brain Monoamine Oxidase in Schizophrenic and Normal Individuals
Schwartz et al.
Arch Gen Psychiatry 1974;31:557-560.
ABSTRACT  

Drugs, Neurotransmitters, and Schizophrenia
Snyder et al.
Science 1974;184:1243-1253.
 





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1973 American Medical Association. All Rights Reserved.